Literature DB >> 8161519

Does adriamycin induce interstrand cross-links in DNA?

C Cullinane1, A van Rosmalen, D R Phillips.   

Abstract

Under nonenzymatic conditions in vitro, Adriamycin appears to form interstrand cross-links with DNA over 1-2 days. This is the first report of such Adriamycin-induced interstrand cross-links in vitro. Cross-links were measured by a fluorescence based renaturation assay and also by gel electrophoresis. Both procedures revealed an increase of cross-linking with reaction time and with increasing Adriamycin concentration and a 5-6-fold enhancement in the presence of Fe3+ ions. The cross-link contains the Adriamycin chromophore, with a lambda max of 508 nm, intercalated at the GpC site of cross-linking. Maximal stoichiometry of the cross-link was one per 11-20 bp. The cross-link appears to involve adducts of the Adriamycin chromophore linked to the N2 of guanine, with no indication that N7 of guanine is involved. Given that the mode of action of Adriamycin still remains obscure, even after 20 years of clinical use, the possibility that interstrand DNA cross-links may be associated with the clinical mechanism of action of this drug should now be fully addressed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161519     DOI: 10.1021/bi00181a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Activity and DNA binding of new organoamidoplatinum (II) complexes.

Authors:  T Talarico; D R Phillips; G B Deacon; S Rainone; L K Webster
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells.

Authors:  C Cullinane; S M Cutts; C Panousis; D R Phillips
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

3.  Stability of adriamycin-induced DNA adducts and interstrand crosslinks.

Authors:  A van Rosmalen; C Cullinane; S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

4.  Characterization of noncovalent complexes formed between minor groove binding molecules and duplex DNA by electrospray ionization-mass spectrometry.

Authors:  D C Galefn; R D Smithcor
Journal:  J Am Soc Mass Spectrom       Date:  1995-12       Impact factor: 3.109

Review 5.  The involvement of DNA-damage and -repair defects in neurological dysfunction.

Authors:  Avanti Kulkarni; David M Wilson
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

6.  Doxazolidine induction of apoptosis by a topoisomerase II independent mechanism.

Authors:  Brian T Kalet; Meagan B McBryde; Joaquin M Espinosa; Tad H Koch
Journal:  J Med Chem       Date:  2007-08-16       Impact factor: 7.446

7.  Characterization of covalent adriamycin-DNA adducts.

Authors:  S M Zeman; D R Phillips; D M Crothers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

8.  Use of oligonucleotides to define the site of interstrand cross-links induced by Adriamycin.

Authors:  S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-07-11       Impact factor: 16.971

9.  IS METABOLIC ACTIVATION OF TOPOISOMERASE II POISONS IMPORTANT IN THE MECHANISM OF CYTOTOXICITY?

Authors:  Birandra K Sinha; Ronald P Mason
Journal:  J Drug Metab Toxicol       Date:  2015-07-24

10.  CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.

Authors:  Benny J Evison; Rebecca A Bilardi; Francis C K Chiu; Gabriella Pezzoni; Don R Phillips; Suzanne M Cutts
Journal:  Nucleic Acids Res       Date:  2009-08-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.